Pyrotinib in HER2-Positive local advanced or metastatic breast cancer patients: Results from a retrospective study in real-world setting

被引：0
|
作者：
Wang, Q. [1 ]
Chen, C. [2 ]
Wang, Y. [3 ]
Sun, S. [2 ]
Cheng, J. [4 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Wuhan, Hubei, Peoples R China
[2] Wuhan Univ, Renmin Hosp, Dept Breast & Thyroid Surg, Wuhan, Hubei, Peoples R China
[3] Hubei Univ Arts & Sci, Affiliated Hosp, Xiangyang Cent Hosp, Wuhan, Xiangyang, Peoples R China
[4] Huazhong Univ Sci & Technol, Ctr Canc, Tongji Med Coll, Union Hosp, Wuhan, Hubei, Peoples R China
来源：
EUROPEAN JOURNAL OF CANCER | 2020年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
235
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [1] Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study
    Zhang, Qiongwen
    He, Ping
    Tian, Tinglun
    Yan, Xi
    Huang, Juan
    Zhang, Zhang
    Zheng, Hong
    Zhong, Xiaorong
    Luo, Ting
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [2] Effectiveness and safety of pyrotinib-based therapy in patients with HER2-positive metastatic breast cancer: A real-world retrospective study
    Li, Chao
    Bian, Xiaoli
    Liu, Zhaoyun
    Wang, Xinzhao
    Song, Xiang
    Zhao, Wei
    Liu, Yansong
    Yu, Zhiyong
    [J]. CANCER MEDICINE, 2021, 10 (23): : 8352 - 8364
  • [3] A multicenter, retrospective, real-world study of inetetamab combined with pyrotinib and vinorelbine as treatment for HER2-positive metastatic breast cancer
    Jin, N.
    Yin, Y.
    Li, W.
    Huang, X.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1492 - S1492
  • [4] Pyrotinib in the Treatment of Women With HER2-Positive Advanced Breast Cancer: A Multicenter, Prospective, Real-World Study
    Zhang, Lili
    Wu, Xiaohong
    Zhou, Jun
    Zhu, Mingzhen
    Yu, Hao
    Zhang, Yusong
    Zhao, Yutian
    Han, Zhengxiang
    Guo, Yujiang
    Guan, Xiaoqing
    Wang, Xufen
    Xu, Hong
    Sun, Li
    Zhang, Jiaxin
    Zhuang, Min
    Xie, Li
    Yu, Shiyou
    Chen, Ping
    Feng, Jifeng
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] Real-world data of triplet combination of pyrotinib, trastuzumab, and chemotherapy in HER2-positive metastatic breast cancer: a multicenter, retrospective study
    You, Shuhui
    Sang, Die
    Xu, Fei
    Luo, Ting
    Yuan, Peng
    Xie, Yizhao
    Wang, Biyun
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [6] REAL-WORLD DATA OF TRIPLET COMBINATION OF PYROTINIB, TRASTUZUMAB, AND CHEMOTHERAPY IN HER2-POSITIVE METASTATIC BREAST CANCER: A MULTICENTER, RETROSPECTIVE STUDY
    Wang, Biyun
    You, Shuhui
    Xie, Yizhao
    Sang, Die
    Xu, Fei
    Luo, Ting
    Yuan, Peng
    [J]. BREAST, 2023, 71 : S52 - S52
  • [7] Real-world outcomes and safety of pyrotinib in HER2-positive metastatic breast cancer (MBC) patients: A prospective cohort study
    Luo, T.
    Zhang, Q.
    He, P.
    Zhong, X.
    Yan, X.
    Tian, T.
    Huang, J.
    Zhang, Z.
    Zheng, H.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S490 - S490
  • [8] Efficacy and safety of pyrotinib-containing regimen in the patients with HER2-positive metastatic breast cancer: A multicenter real-world study
    Yin, Sha
    Chi, Yajing
    Du, Yangyang
    Wang, Jingfen
    Shan, Changping
    Yi, Weiwei
    Shang, Mao
    Man, Xiaochu
    Tan, Qiaorui
    Li, Huihui
    [J]. CANCER MEDICINE, 2023, 12 (03): : 2333 - 2344
  • [9] Real-world outcomes associated with pyrotinib-based therapy for HER2-positive metastatic breast cancer
    Hao, L.
    Chen, J.
    Chen, M.
    Han, X.
    Pan, Y.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S489 - S489
  • [10] A Multicenter, Retrospective, Real World Study of Inetetamab Combined with Pyrotinib and Vinorelbine as Treatment for HER2-positive Metastatic Breast Cancer
    Yin, Yongmei
    Li, Wei
    Huang, Xiang
    Jin, Nan
    Wu, Xinyu
    Sun, Chunxiao
    Hua, Yijia
    [J]. CANCER RESEARCH, 2024, 84 (09)
12345